c-MYC Activation in Primary and Metastatic Ductal Adenocarcinoma of the Pancreas: Incidence, Mechanisms, and Clinical Significance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://www.nature.com/articles/3880547.pdf
Reference27 articles.
1. Sakorafas GH, Tsiotou AG, Tsiotos GG . Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000; 26: 29–52.
2. Sirivatanauksorn V, Sirivatanauksorn Y, Lemoine NR . Molecular pattern of ductal pancreatic cancer. Langenbecks Arch Surg 1998; 383: 105–115.
3. Schleger C, Arens N, Zentraf H, Bleyl U, Verbeke C . Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridisation (CGH). J Pathol 2000; 191: 27–32.
4. Mahlamäki EH, Höglund M, Gorunova L, Karhu R, Dawiskiba S, Andrén-Sandberg Å, et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosom Cancer 1997; 20: 383–391.
5. Armengol G, Knuutila S, Lluís F, Capellá G, Miró R, Caballín MR . DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. Cancer Genet Cytogenet 2000; 116: 133–141.
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma;Cancer Gene Therapy;2024-09-04
2. Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma;2024-07-02
3. Metabolite-Based Biosignature of Pancreatic Cancer;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024
4. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in Pancreatic Ductal Adenocarcinoma;2023-12-08
5. Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer;Cancer Cell;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3